ATE105482T1 - Behandlung von krebs mit somatostatin und mit analogen davon. - Google Patents

Behandlung von krebs mit somatostatin und mit analogen davon.

Info

Publication number
ATE105482T1
ATE105482T1 AT8989901170T AT89901170T ATE105482T1 AT E105482 T1 ATE105482 T1 AT E105482T1 AT 8989901170 T AT8989901170 T AT 8989901170T AT 89901170 T AT89901170 T AT 89901170T AT E105482 T1 ATE105482 T1 AT E105482T1
Authority
AT
Austria
Prior art keywords
somatostatin
cancer
analogs
treatment
analog
Prior art date
Application number
AT8989901170T
Other languages
English (en)
Inventor
John E Taylor
Arthur E Bogden
Jacques-Pierre Moreau
David H Coy
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE105482T1 publication Critical patent/ATE105482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT8989901170T 1987-11-18 1988-11-18 Behandlung von krebs mit somatostatin und mit analogen davon. ATE105482T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12193787A 1987-11-18 1987-11-18
US07/231,136 US5073541A (en) 1987-11-18 1988-08-11 Treatment of small cell lung cancer with somatostatin analogs
PCT/US1988/004126 WO1989004666A1 (en) 1987-11-18 1988-11-18 Treatment of cancer with somatostatin and analogs thereof

Publications (1)

Publication Number Publication Date
ATE105482T1 true ATE105482T1 (de) 1994-05-15

Family

ID=26819987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT8989901170T ATE105482T1 (de) 1987-11-18 1988-11-18 Behandlung von krebs mit somatostatin und mit analogen davon.

Country Status (8)

Country Link
US (1) US5073541A (de)
EP (1) EP0344297B1 (de)
JP (1) JPH02502022A (de)
AT (1) ATE105482T1 (de)
CA (1) CA1330037C (de)
DE (1) DE3889536T2 (de)
IE (1) IE65809B1 (de)
WO (1) WO1989004666A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441935A (en) * 1987-03-31 1995-08-15 Imperial Cancer Research Technology Ltd. Growth factor receptors
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
GR1002475B (el) * 1988-12-05 1996-11-26 Novartis Ag (Novartis Sa) (Novartis Inc.) Μεθοδος παρασκευης πεπτιδικων παραγωγων.
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5411943A (en) * 1992-02-25 1995-05-02 Biomeasure, Inc. Hepatoma treatment with somatostatin analogs
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5569741A (en) * 1992-07-27 1996-10-29 Biomeasure, Inc. Cyclic octapeptide neuromedin B receptor antagonists
CA2118588A1 (en) * 1992-07-27 1994-02-03 David H. Coy Neuromedin b receptor antagonists
US5462926A (en) * 1992-07-27 1995-10-31 Biomeasure, Inc. Neuromedin B receptor antagonists which demonstrate selectivity
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
KR100479149B1 (ko) * 1996-12-04 2005-03-25 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 소마토스타틴 길항제
US6150333A (en) * 1998-07-30 2000-11-21 Biomeasure, Inc. Methods of using a somatostatin analogue
US6465613B1 (en) 1998-11-19 2002-10-15 Tulane University Hydrophilic somatostatin analogs
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
AU2002341792B2 (en) 2001-09-21 2007-09-06 The Administrators Of The Tulane Educational Fund Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
IL163573A0 (en) * 2002-03-01 2005-12-18 Univ Tulane Conjugates of therapeutic or cytotoxic agents and biologically active peptides
WO2004009614A2 (en) * 2002-07-24 2004-01-29 The Salk Institute For Biological Studies Receptor (sstr4)- selective somatostatin analogs
AU2004220104A1 (en) * 2003-03-10 2004-09-23 Biogen Idec Inc. Thiol-mediated drug attachment to targeting peptides
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
EP3488848A1 (de) * 2012-01-17 2019-05-29 Tyme, Inc. Tyrosinhydroxylase-inhibitoren zur verwendung bei der behandlung von krebs
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
JP2021530568A (ja) 2018-07-19 2021-11-11 ヤモ・ファーマシューティカルズ・エルエルシー 自閉症を処置するための組成物および方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4133782A (en) * 1976-06-07 1979-01-09 The Salk Institute For Biological Studies Somatostatin analogs with dissociated biological activities
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4328135A (en) * 1980-06-13 1982-05-04 American Home Products Corporation Octapeptides lowering growth hormone
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4820811A (en) * 1982-04-21 1989-04-11 Research Corporation Amine reacted therapeutic agents
DE3303345A1 (de) * 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Cyclische peptide mit somatostatin-wirkung
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4816438A (en) * 1984-08-31 1989-03-28 The Salk Institute For Biological Studies Insulin-selective somatostatin analogs
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
US4703034A (en) * 1986-04-28 1987-10-27 Merck & Co., Inc. Novel cyclic tetrapeptide

Also Published As

Publication number Publication date
CA1330037C (en) 1994-06-07
DE3889536D1 (de) 1994-06-16
JPH02502022A (ja) 1990-07-05
IE883450L (en) 1989-05-18
EP0344297A4 (en) 1990-10-03
US5073541A (en) 1991-12-17
WO1989004666A1 (en) 1989-06-01
DE3889536T2 (de) 1994-11-24
IE65809B1 (en) 1995-11-15
EP0344297B1 (de) 1994-05-11
EP0344297A1 (de) 1989-12-06

Similar Documents

Publication Publication Date Title
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
ATE281840T1 (de) Behandlung von diarrhoe
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
RU95106651A (ru) Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
NO933044D0 (no) Fremgangsmaate for behandling av osteoporose
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
IT8619055A0 (it) Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria.
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE68913907D1 (de) Methode zur Behandlung des interstitiellen Blasenentzündung.
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
ATE149840T1 (de) Behandlung von leberkrebs
DE3875637D1 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
EP0235904A3 (de) Behandlung von Allergie mit Thymopentin
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
ES8204713A1 (es) Un procedimiento para aislar un polipeptido purificado
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee